Lars Bauer
- Pathology and Forensic Medicine top 0.5%
- Multiple Sclerosis Research Studies 13
- Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments 23
- Botulinum Toxin and Related Neurological Disorders 13
- Neurological disorders and treatments 13
- Peripheral Neuropathies and Disorders 7
- Rheumatology top 0.5%
- Spondyloarthritis Studies and Treatments 24
- Rheumatoid Arthritis Research and Therapies 21
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis 15
- Hematology top 5%
- Co-authors
- Rupert SandbrinkLudwig KapposFrederik BarkhofXavier MontalbánGilles EdanMark S. FreedmanChristoph PohlDavid H. Miller
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Lars Bauer
64 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Pathology and Forensic Medicine 1.9k
- Neurology 1.4k
- Rheumatology 1.1k
- Immunology 497
- Hematology 210
Countries citing papers authored by Lars Bauer
This map shows the geographic impact of Lars Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Bauer more than expected).
Fields of papers citing papers by Lars Bauer
This network shows the impact of papers produced by Lars Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Bauer. The network helps show where Lars Bauer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Bauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 16 | |
| 6 | 2020 | 47 | |
| 7 | 2020 | 22 | |
| 8 | 2020 | 4 | |
| 9 | 2018 | 30 | |
| 10 | 2018 | 90 | |
| 11 | 2017 | 18 | |
| 12 | 2016 | 13 | |
| 13 | 2016 | 8 | |
| 14 | 2016 | 46 | |
| 15 | 2015 | 12 | |
| 16 | 2014 | 36 | |
| 17 | 2009 | 16 | |
| 18 | Betaferon (R)/betaseron (R) in newly emerging multiple sclerosis for initial treatment (benefit): Effects of early vs. delayed treatment with interferon beta-1B | 2007 | 0 |
| 19 | 2007 | 200 | |
| 20 | Betaferon in newly emerging multiple sclerosis for initial treatment (BENEFIT): First results | 2005 | 3 |
About Lars Bauer
Lars Bauer is a scholar working on Rheumatology, Neurology and Pathology and Forensic Medicine, having authored 67 papers that have together received 3.0k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (24 papers), Parkinson's Disease Mechanisms and Treatments (23 papers), Rheumatoid Arthritis Research and Therapies (21 papers), Psoriasis: Treatment and Pathogenesis (15 papers), Botulinum Toxin and Related Neurological Disorders (13 papers), Multiple Sclerosis Research Studies (13 papers), Neurological disorders and treatments (13 papers) and Peripheral Neuropathies and Disorders (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.9k citations), Neurology (1.4k citations) and Rheumatology (1.1k citations). Lars Bauer has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Rupert Sandbrink, Ludwig Kappos, Frederik Barkhof, Xavier Montalbán, Gilles Edan, Mark S. Freedman, Christoph Pohl, David H. Miller, Chris H. Polman and HP Hartung. Their work appears in journals such as Annals of the Rheumatic Diseases, BMC Neurology, RMD Open, Neurology and Journal of Parkinson s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.